Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Alteogen will hold an Investor Relations (IR) conference for major domestic and foreign institutional investors at Shinhan Securities headquarters on May 16, 2024, to enhance investor understanding.
📊 [Key Disclosure Details & Financial Highlights]
- Event Date & Time: May 16, 2024, 14:00 – 15:00 (Local Time)
- Venue & Sponsor: Shinhan Securities Headquarters
- Target Audience: Major domestic and foreign institutional investors
- Purpose: Enhancing major investors’ understanding of the company through an IR session
- Format/Method: Conducted upon request from Shinhan Securities
- Key Agenda: Company presentation and FAQ
- Date of Confirmation: 2024-04-29
- Contact Department: IR Group (Manager Sigyun Park) / Tel: +82-42-384-8777
- IR Material Posting Date & Location: Scheduled for May 16, 2024, on the Korea Exchange KIND website (http://kind.krx.co.kr)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Why Verifying IR Material Release and Disclosed Information Is Necessary
This filing is an informational disclosure notifying the schedule and publication plans for an IR session held for major domestic and foreign institutional investors.
Checking this follow-up item is necessary because confirming that the official IR presentation material is published on the Korea Exchange KIND website according to the scheduled date (May 16, 2024) is essential. Verifying that the corporate presentation materials disclosed on the event date are properly made available through official channels ensures the final verification of the disclosed facts.
The presentation materials can be verified on the Korea Exchange KIND website (http://kind.krx.co.kr) or through future related filings on DART.
📢 Disclaimer & Source Information
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.
